Newsfile Corp
27 Jul 2026, 18:51 UTC · 7w ago
Verdict
Headline leans bearish. We score Z −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
ADMA Biologics is accused of using channel stuffing to artificially inflate its reported revenue.
More negative than 98% of claims this week
A class action securities lawsuit has been filed against ADMA Biologics alleging the company lacked adequate internal controls and failed to disclose material information.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 91% of claims this week
ADMA Biologics is alleged to have engaged in undisclosed related party transactions.
More negative than 80% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a securities fraud class action arising from alleged anticompetitive agreements.
More negative than 96% of ticker scores this week
The company is the subject of a class action lawsuit with an upcoming application deadline.
More negative than 96% of ticker scores this week
The company is facing a securities class action following a 70% stock decline and undisclosed growth obstacles.
More negative than 96% of ticker scores this week
The company is facing a class action securities lawsuit alleging fraud, channel stuffing, and lack of internal controls.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
20m ago
+4.1%
Price is moving against the score
$32.02 vs $30.76 close before publication (Jul 24) · not market-adjusted
Z chart →
